MB, Levis & Associates’s iShares iBonds Dec 2034 Term Corporate ETF IBDZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$12.5M Sell
507,715
-7,836
-2% -$200K 4.58% 10
2026
Q2
$13.4M Buy
515,551
+4,902
+1% +$128K 4.95% 8
2026
Q1
$13.3M Buy
510,649
+6,463
+1% +$170K 5.55% 8
2025
Q4
$13.3M Buy
504,186
+6,094
+1% +$161K 5.6% 8
2025
Q3
$13.2M Buy
498,092
+1,543
+0.3% +$40.4K 5.71% 7
2025
Q2
$13M Buy
496,549
+8,145
+2% +$208K 5.7% 8
2025
Q1
$12.6M Buy
488,404
+2,146
+0.4% +$54.8K 5.85% 8
2024
Q4
$12.4M Buy
486,258
+4,485
+0.9% +$116K 6.2% 7
2024
Q3
$12.9M Buy
+481,773
New +$12.6M 6.35% 7

Other funds holding IBDZ

MB, Levis & Associates's IBDZ Position: Q3 2026 in Review

MB, Levis & Associates reduced its iShares iBonds Dec 2034 Term Corporate ETF (IBDZ) stake by 1.5% in Q3 2026, selling an estimated $200K and leaving 507,715 shares worth $12.5M. The position accounts for 4.58% of the portfolio, ranked #10.

MB, Levis & Associates first reported a position in IBDZ in Q3 2024 and has held it in 9 quarters since. The position peaked at $13.4M in Q2 2026. 23 funds tracked by Wall St. Rank hold IBDZ as of Q3 2026.

  • MB, Levis & Associates held 507,715 shares of iShares iBonds Dec 2034 Term Corporate ETF worth $12.5M as of Q3 2026.
  • MB, Levis & Associates sold 7,836 iShares iBonds Dec 2034 Term Corporate ETF shares in Q3 2026, an estimated $200K.
  • iShares iBonds Dec 2034 Term Corporate ETF made up 4.58% of MB, Levis & Associates's portfolio in Q3 2026, its #10 holding.
  • MB, Levis & Associates first reported a position in iShares iBonds Dec 2034 Term Corporate ETF in Q3 2024 and has held it in 9 quarters since.
  • MB, Levis & Associates's iShares iBonds Dec 2034 Term Corporate ETF position peaked at $13.4M in Q2 2026.
  • 23 funds tracked by Wall St. Rank held iShares iBonds Dec 2034 Term Corporate ETF as of Q3 2026.

Based on MB, Levis & Associates's 13F filing for Q3 2026, filed 16 Oct 2026.